Foster Dykema Cabot & Partners, LLC Amgen Inc Call Options Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMGN
# of Institutions
3,085Shares Held
417MCall Options Held
7.24MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.9 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$15 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.42 Billion0.4% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.67 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.64 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $174B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...